These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


342 related items for PubMed ID: 8513649

  • 1. Clinical pharmacokinetics of alprazolam. Therapeutic implications.
    Greenblatt DJ, Wright CE.
    Clin Pharmacokinet; 1993 Jun; 24(6):453-71. PubMed ID: 8513649
    [Abstract] [Full Text] [Related]

  • 2. Alprazolam pharmacokinetics, metabolism, and plasma levels: clinical implications.
    Greenblatt DJ, von Moltke LL, Harmatz JS, Ciraulo DA, Shader RI.
    J Clin Psychiatry; 1993 Oct; 54 Suppl():4-11; discussion 12-4. PubMed ID: 8262889
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics and clinical effects of alprazolam following single and multiple oral doses in patients with panic disorder.
    Ciraulo DA, Barnhill JG, Boxenbaum HG, Greenblatt DJ, Smith RB.
    J Clin Pharmacol; 1986 Apr; 26(4):292-8. PubMed ID: 2871050
    [Abstract] [Full Text] [Related]

  • 4. The pharmacology of alprazolam: a review.
    Huybrechts I.
    Clin Ther; 1991 Apr; 13(1):100-17. PubMed ID: 2029716
    [Abstract] [Full Text] [Related]

  • 5. The relationship of alprazolam dose to steady-state plasma concentrations.
    Ciraulo DA, Antal EJ, Smith RB, Olson DR, Goldberg DA, Rand EH, Raskin RB, Phillips JP, Shader RI, Greenblatt DJ.
    J Clin Psychopharmacol; 1990 Feb; 10(1):27-32. PubMed ID: 2407754
    [Abstract] [Full Text] [Related]

  • 6. Benzodiazepine drug-drug interactions commonly occurring in clinical practice.
    Abernethy DR, Greenblatt DJ, Ochs HR, Shader RI.
    Curr Med Res Opin; 1984 Feb; 8 Suppl 4():80-93. PubMed ID: 6144465
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics of the newer benzodiazepines.
    Garzone PD, Kroboth PD.
    Clin Pharmacokinet; 1989 Jun; 16(6):337-64. PubMed ID: 2567646
    [Abstract] [Full Text] [Related]

  • 8. Coadministration of nefazodone and benzodiazepines: III. A pharmacokinetic interaction study with alprazolam.
    Greene DS, Salazar DE, Dockens RC, Kroboth P, Barbhaiya RH.
    J Clin Psychopharmacol; 1995 Dec; 15(6):399-408. PubMed ID: 8748428
    [Abstract] [Full Text] [Related]

  • 9. Clinical pharmacokinetics and pharmacodynamics of zolpidem. Therapeutic implications.
    Salvà P, Costa J.
    Clin Pharmacokinet; 1995 Sep; 29(3):142-53. PubMed ID: 8521677
    [Abstract] [Full Text] [Related]

  • 10. Differences in pharmacodynamics but not pharmacokinetics between subjects with panic disorder and healthy subjects after treatment with a single dose of alprazolam.
    Kaplan GB, Greenblatt DJ, Ehrenberg BL, Goddard JE, Harmatz JS, Shader RI.
    J Clin Psychopharmacol; 2000 Jun; 20(3):338-46. PubMed ID: 10831021
    [Abstract] [Full Text] [Related]

  • 11. Bromazepam pharmacokinetics: influence of age, gender, oral contraceptives, cimetidine, and propranolol.
    Ochs HR, Greenblatt DJ, Friedman H, Burstein ES, Locniskar A, Harmatz JS, Shader RI.
    Clin Pharmacol Ther; 1987 May; 41(5):562-70. PubMed ID: 2882883
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics in lactating women: prediction of alprazolam transfer into milk.
    Oo CY, Kuhn RJ, Desai N, Wright CE, McNamara PJ.
    Br J Clin Pharmacol; 1995 Sep; 40(3):231-6. PubMed ID: 8527284
    [Abstract] [Full Text] [Related]

  • 13. Lack of interaction between disulfiram and alprazolam in alcoholic patients.
    Diquet B, Gujadhur L, Lamiable D, Warot D, Hayoun H, Choisy H.
    Eur J Clin Pharmacol; 1990 Sep; 38(2):157-60. PubMed ID: 2338112
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics of an extended release formulation of alprazolam (Xanax XR) in healthy normal adolescent and adult volunteers.
    Glue P, Fang A, Gandelman K, Klee B.
    Am J Ther; 2006 Sep; 13(5):418-22. PubMed ID: 16988537
    [Abstract] [Full Text] [Related]

  • 15. Interaction of cimetidine with the triazolobenzodiazepines alprazolam and triazolam.
    Abernethy DR, Greenblatt DJ, Divoll M, Moschitto LJ, Harmatz JS, Shader RI.
    Psychopharmacology (Berl); 1983 Sep; 80(3):275-8. PubMed ID: 6137021
    [Abstract] [Full Text] [Related]

  • 16. Fluoxetine impairs clearance of alprazolam but not of clonazepam.
    Greenblatt DJ, Preskorn SH, Cotreau MM, Horst WD, Harmatz JS.
    Clin Pharmacol Ther; 1992 Nov; 52(5):479-86. PubMed ID: 1424422
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics, pharmacodynamics, and treatment issues of benzodiazepines: alprazolam, adinazolam, and clonazepam.
    DeVane CL, Ware MR, Lydiard RB.
    Psychopharmacol Bull; 1991 Nov; 27(4):463-73. PubMed ID: 1687613
    [Abstract] [Full Text] [Related]

  • 18. Clinical pharmacokinetics and pharmacodynamics of buspirone, an anxiolytic drug.
    Mahmood I, Sahajwalla C.
    Clin Pharmacokinet; 1999 Apr; 36(4):277-87. PubMed ID: 10320950
    [Abstract] [Full Text] [Related]

  • 19. Clinical pharmacokinetics of anxiolytics and hypnotics in the elderly. Therapeutic considerations (Part I).
    Greenblatt DJ, Harmatz JS, Shader RI.
    Clin Pharmacokinet; 1991 Sep; 21(3):165-77. PubMed ID: 1684924
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics and psychomotor performance of alprazolam: concentration-effect relationship.
    Wright CE, Sisson TL, Fleishaker JC, Antal EJ.
    J Clin Pharmacol; 1997 Apr; 37(4):321-9. PubMed ID: 9115058
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.